Toward an integrated map of genetic interactions in cancer cells

Cancer genomes often harbor hundreds of molecular aberrations. Such genetic variants can be drivers or passengers of tumorigenesis and create vulnerabilities for potential therapeutic exploitation. To identify genotype‐dependent vulnerabilities, forward genetic screens in different genetic backgrounds have been conducted. We devised MINGLE, a computational framework to integrate CRISPR/Cas9 screens originating from different libraries building on approaches pioneered for genetic network discovery in model organisms. We applied this method to integrate and analyze data from 85 CRISPR/Cas9 screens in human cancer cells combining functional data with information on genetic variants to explore more than 2.1 million gene‐background relationships. In addition to known dependencies, we identified new genotype‐specific vulnerabilities of cancer cells. Experimental validation of predicted vulnerabilities identified GANAB and PRKCSH as new positive regulators of Wnt/β‐catenin signaling. By clustering genes with similar genetic interaction profiles, we drew the largest genetic network in cancer cells to date. Our scalable approach highlights how diverse genetic screens can be integrated to systematically build informative maps of genetic interactions in cancer, which can grow dynamically as more data are included.

[1]  N. Dahms,et al.  Glucosidase II and MRH-domain containing proteins in the secretory pathway. , 2015, Current protein & peptide science.

[2]  Adam P. Rosebrock,et al.  A global genetic interaction network maps a wiring diagram of cellular function , 2016, Science.

[3]  A. Fukui,et al.  Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling , 2015, Molecular and Cellular Biology.

[4]  Julio Saez-Rodriguez,et al.  A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia , 2016, Cell reports.

[5]  D. Durocher,et al.  Evaluation and Design of Genome-Wide CRISPR / SpCas 9 Knockout Screens , 2017 .

[6]  M. Boutros,et al.  Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  K. Basler,et al.  Porcupine-mediated lipidation is required for Wnt recognition by Wls. , 2012, Developmental biology.

[8]  Wolfgang Huber,et al.  Mapping of signaling networks through synthetic genetic interaction analysis by RNAi , 2011, Nature Methods.

[9]  D. Durocher,et al.  Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens , 2017, G3: Genes, Genomes, Genetics.

[10]  S. Scholpp,et al.  Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β‐catenin signalling , 2014, EMBO reports.

[11]  Jan Winter,et al.  CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries , 2016, Genome Biology.

[12]  B. Garvik,et al.  Principles for the Buffering of Genetic Variation , 2001, Science.

[13]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[14]  D. Sidransky,et al.  Role of the p16 tumor suppressor gene in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[16]  P. Phillips Epistasis — the essential role of gene interactions in the structure and evolution of genetic systems , 2008, Nature Reviews Genetics.

[17]  Michael Boutros,et al.  Regulation of Wnt protein secretion and its role in gradient formation , 2008, EMBO reports.

[18]  G. Casari,et al.  A reversible gene trap collection empowers haploid genetics in human cells , 2013, Nature Methods.

[19]  S. Grossman,et al.  Mechanisms of mutant p53 stabilization in cancer. , 2014, Sub-cellular biochemistry.

[20]  R. DePinho,et al.  Collateral Lethality: A new therapeutic strategy in oncology. , 2015, Trends in cancer.

[21]  Julio Collado-Vides,et al.  BClass: A Bayesian Approach Based on Mixture Models for Clustering and Classification of Heterogeneous Biological Data , 2004 .

[22]  R. Sakthivel,et al.  Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets. , 2016, Biochimica et biophysica acta.

[23]  Judith B. Zaugg,et al.  Data-driven hypothesis weighting increases detection power in genome-scale multiple testing , 2016, Nature Methods.

[24]  Per B. Brockhoff,et al.  lmerTest Package: Tests in Linear Mixed Effects Models , 2017 .

[25]  V. Rotter,et al.  Mutant p53 gain-of-function in cancer. , 2010, Cold Spring Harbor perspectives in biology.

[26]  Michael Boutros,et al.  Secretion of Wnt Ligands Requires Evi, a Conserved Transmembrane Protein , 2006, Cell.

[27]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[28]  A. Bergman,et al.  Evolutionary capacitance as a general feature of complex gene networks , 2003, Nature.

[29]  Brock F. Binkowski,et al.  Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.

[30]  Ralf Herwig,et al.  The ConsensusPathDB interaction database: 2013 update , 2012, Nucleic Acids Res..

[31]  Antoine de Weck,et al.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.

[32]  T. Golub,et al.  Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.

[33]  Gary D Bader,et al.  Quantitative analysis of fitness and genetic interactions in yeast on a genome scale , 2010, Nature Methods.

[34]  M. Boutros,et al.  A map of directional genetic interactions in a metazoan cell , 2015, eLife.

[35]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[36]  E. Lander,et al.  Identification and characterization of essential genes in the human genome , 2015, Science.

[37]  W. de Lau,et al.  The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength , 2014, Genes & development.

[38]  Marketa Zvelebil,et al.  High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing , 2011, Genome Biology.

[39]  Lei S. Qi,et al.  Genetic interaction mapping in mammalian cells using CRISPR interference , 2017, Nature Methods.

[40]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[41]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[42]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[43]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[44]  D. Morgens,et al.  Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes , 2016, Nature Biotechnology.

[45]  Kristian Cibulskis,et al.  RNF43 is frequently mutated in colorectal and endometrial cancers , 2014, Nature Genetics.

[46]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[47]  K. Basler,et al.  Wntless, a Conserved Membrane Protein Dedicated to the Secretion of Wnt Proteins from Signaling Cells , 2006, Cell.

[48]  G. Traver Hart,et al.  BAGEL: a computational framework for identifying essential genes from pooled library screens , 2015, BMC Bioinformatics.

[49]  Joshua M. Korn,et al.  CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. , 2016, Cancer discovery.

[50]  C. Bradshaw,et al.  Strength of evidence for density dependence in abundance time series of 1198 species. , 2006, Ecology.

[51]  M. Waterman,et al.  A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. , 2012, Differentiation; research in biological diversity.

[52]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[53]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[54]  S. Ormanns,et al.  WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling , 2014, Oncotarget.

[55]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[56]  Jing-he Li,et al.  SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer , 2016, Cancer investigation.

[57]  L. Trusolino,et al.  Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.

[58]  M. Carl,et al.  RAB8B is required for activity and caveolar endocytosis of LRP6. , 2013, Cell reports.

[59]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[60]  Ji Luo,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[61]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[62]  Gary D Bader,et al.  Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.

[63]  T. Ideker,et al.  Systematic interpretation of genetic interactions using protein networks , 2005, Nature Biotechnology.

[64]  Thomas D. Wu,et al.  A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.

[65]  Aaron N. Chang,et al.  Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions , 2017, Nature Methods.

[66]  Anastasia Baryshnikova,et al.  Exploratory Analysis of Biological Networks through Visualization, Clustering, and Functional Annotation in Cytoscape. , 2016, Cold Spring Harbor protocols.

[67]  R. Punnett,et al.  The Genetical Theory of Natural Selection , 1930, Nature.

[68]  Chengchao Xu,et al.  Glycosylation-directed quality control of protein folding , 2015, Nature Reviews Molecular Cell Biology.

[69]  W. Kaelin The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.

[70]  Trey Ideker,et al.  A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. , 2016, Molecular cell.

[71]  R. Barrangou Cas9 Targeting and the CRISPR Revolution , 2014, Science.

[72]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[73]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[74]  Huiming Ding,et al.  The synthetic genetic interaction spectrum of essential genes , 2005, Nature Genetics.

[75]  Lucas Pelkmans,et al.  Predicting functional gene interactions with the hierarchical interaction score , 2013, Nature Methods.

[76]  Feng Cong,et al.  Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[77]  Neville E. Sanjana,et al.  High-throughput functional genomics using CRISPR–Cas9 , 2015, Nature Reviews Genetics.

[78]  Michael Boutros,et al.  Towards a compendium of essential genes – From model organisms to synthetic lethality in cancer cells , 2015, Critical reviews in biochemistry and molecular biology.

[79]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[80]  Martin Kampmann,et al.  Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells , 2013, Proceedings of the National Academy of Sciences.

[81]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[82]  Hans-Werner Mewes,et al.  CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..

[83]  Joshua M. Stuart,et al.  A global analysis of genetic interactions in Caenorhabditis elegans , 2007, Journal of biology.

[84]  Eric S. Lander,et al.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.

[85]  Michael Boutros,et al.  The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.

[86]  P. Yaswen,et al.  A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells , 2009, PloS one.

[87]  S. Elledge,et al.  A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. , 2017, Cell reports.

[88]  Robert P. St.Onge,et al.  Defining genetic interaction , 2008, Proceedings of the National Academy of Sciences.

[89]  A. Joe,et al.  Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.

[90]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[91]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[92]  Hans Clevers,et al.  Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors , 2016, Nature Medicine.

[93]  M. Boutros,et al.  A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling , 2012, Molecular and Cellular Biology.

[94]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[95]  T. Belenkaya,et al.  Roles of N-glycosylation and lipidation in Wg secretion and signaling. , 2012, Developmental biology.

[96]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[97]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  A. Berns,et al.  Drugging the addict: non‐oncogene addiction as a target for cancer therapy , 2016, EMBO reports.

[99]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[100]  Jan Winter,et al.  GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens , 2016, Nucleic Acids Res..

[101]  R. Fisher Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.

[102]  S. Nijman Synthetic lethality: General principles, utility and detection using genetic screens in human cells , 2011, FEBS letters.

[103]  M. Raaben,et al.  Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling , 2017, Nature.

[104]  Max A. Horlbeck,et al.  Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.

[105]  Hideki Yamamoto,et al.  Glycosylation and palmitoylation of Wnt‐3a are coupled to produce an active form of Wnt‐3a , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[106]  R. Bernards,et al.  CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes , 2016, Nature Biotechnology.

[107]  Calvin B. Bridges,et al.  The Origin of Variations in Sexual and Sex-Limited Characters , 1922, The American Naturalist.

[108]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[109]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[110]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[111]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[112]  Wolfgang Huber,et al.  Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping , 2013, Nature Methods.

[113]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[114]  A. McMahon,et al.  Wnt family proteins are secreted and associated with the cell surface. , 1993, Molecular biology of the cell.